Newswise — August 2, 2016 – The high levels of caffeine in energy drinks may lead to cardiac complications, suggests a case report in the July/August Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM). The journal is published by Wolters Kluwer.
The case adds to previous reports of adverse cardiovascular events related to consuming energy drinks, including abnormal heart rhythms (arrhythmias). The lead author is Dr. Maryam Sattari of University of Florida, Gainesville.
Arrhythmia Sends Energy Drink User to the Emergency RoomThe patient was a 28-year-old man seen in the emergency department after developing vomiting with blood. On examination, the only abnormality (other than obesity) was a very fast heart rate—about 130 beats per minute.
An electrocardiogram revealed an abnormal heart rhythm called atrial fibrillation: a common type of arrhythmia that can lead to serious complications if sustained. Further tests showed no other heart problems.
The patient said he routinely drank two Monster energy drinks per day—for a total caffeine content of 320 milligrams—along with two or three beers. No other common causes of his heart rhythm abnormality were apparent.
With medications, the atrial fibrillation resolved over 48 hours. Endoscopy showed a tear of the stomach and esophagus, probably caused by forceful vomiting. The patient was sent home in stable condition; at one year's follow-up, he had no further symptoms of arrhythmia.
Although several factors might have contributed to the patient's atrial fibrillation, Dr. Sattari and colleagues write, "We believe that energy drink consumption played a key role." They point out the 160 mg caffeine content of a Monster energy drink is about four times higher than in a caffeinated soft drink (The caffeine content of coffee drinks varies widely, but may be even higher).
A review of the medical research identified at least eight cases of cardiovascular events linked to energy drinks, such as Monster or Red Bull. The researchers discuss several mechanisms by which the high caffeine content of these products might lead to cardiovascular events. These include other ingredients, such as taurine, that might heighten the effects of caffeine; using energy drinks along with alcohol or illicit drugs; or high stress levels.
Energy drinks have become increasingly popular in recent years, especially among adolescents and young adults. Marketed as "nutritional supplements," these beverages are not subject to the caffeine limits on soft drinks, or to the safety testing and labeling required for medications.
This and previous reports are "suggestive but not conclusive" that the caffeine in energy drinks may cause abnormal heart rhythms and other cardiac complications. "We suggest that arrhythmia could be a complication of energy drink consumption," Dr. Sattari and coauthors write. They encourage health care providers to ask about energy drink intake in otherwise healthy young patients with unexplained arrhythmias.
Article: "Energy Drink Consumption and Cardiac Complications: A Case for Caution" (doi: 10.1097/ADM.0000000000000234)
About Journal of Addiction MedicineThe mission of Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine, is to promote excellence in the practice of addiction medicine and in clinical research as well as to support Addiction Medicine as a mainstream medical specialty. Published quarterly, the Journal is designed for all physicians and other mental health professionals who need to keep up-to-date with the treatment of addiction disorders. Under the guidance of an esteemed Editorial Board, peer-reviewed articles published in the Journal focus on developments in addiction medicine as well as on treatment innovations and ethical, economic, forensic, and social topics.
About The American Society of Addiction MedicineThe American Society of Addiction Medicine is a national medical specialty society of over 3,700 physicians and associated health professionals. Its mission is to increase access to and improve the quality of addiction treatment, to educate physicians, and other health care providers and the public, to support research and prevention, to promote the appropriate role of the physician in the care of patients with addictive disorders, and to establish addiction medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care services and the general public. ASAM was founded in 1954, and has had a seat in the American Medical Association House of Delegates since 1988. Follow ASAM’s official Twitter handle: @ASAMorg
About Wolters KluwerWolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwerhealth.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.
MEDIA CONTACTRegister for reporter access to contact details
Journal of Addiction Medicine